Lessons learned from 1,000 neobladders: the 90-day complication rate

The Journal of Urology
Richard E HautmannBjoern G Volkmer

Abstract

We report the 90-day morbidity of the ileal neobladder in a large, contemporary, homogenous series of patients who underwent radical cystectomy at a tertiary academic referral center using a standard approach. Between January 1986 and September 2008 we performed 1,540 radical cystectomies. A total of 281 patients had an absolute contraindication for orthotopic reconstruction. The remaining 1,259 patients were candidates for a neobladder. Of these patients 1,013 (66%) finally received a neobladder and form the basis of this report. All patients had a thorough followup until December 2008 or until death. All complications within 90 days of surgery were defined, categorized and classified by an established 5 grade and 11 domain modification of the original Clavien system. Of 1,013 patients 587 (58%) experienced at least 1 complication within 90 days of surgery. Infectious complications were most common (24%) followed by genitourinary (17%), gastrointestinal (15%) and wound related complications (9%). The 90-day mortality rate was 2.3%. Of the patients 36% had minor (grade 1 to 2) and 22% had major (grade 3 to 5) complications. On univariate analysis the incidence and severity of the 90-day complications rate correlate highly signi...Continue Reading

References

Jun 17, 2004·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Harry W HerrE David Crawford
Sep 8, 2005·The Journal of Urology·Brent K HollenbeckJohn T Wei
Dec 6, 2005·Critical Reviews in Oncology/hematology·Fiona C BurkhardUrs E Studer
Feb 14, 2006·The Journal of Urology·Marcus L QuekDonald G Skinner
Aug 15, 2006·European Urology·Vladimir NovotnyManfred P Wirth
Oct 20, 2006·European Urology·Richard E Hautmann

❮ Previous
Next ❯

Citations

Mar 8, 2012·World Journal of Urology·In Gab JeongChoung-Soo Kim
Nov 13, 2012·World Journal of Urology·Massimo PorenaAntonella Giannantoni
Oct 21, 2011·Journal of Endourology·Hyun Hwan SungByong Chang Jeong
Nov 9, 2012·Journal of Endourology·Stavros I TyritzisN Peter Wiklund
Feb 12, 2011·Current Opinion in Oncology·Todd M MorganPeter E Clark
Sep 29, 2012·Advances in Urology·Matthew E HyndmanTrinity J Bivalacqua
Feb 4, 2014·Expert Review of Anticancer Therapy·Andrea MinerviniMarco Carini
Feb 11, 2015·Scandinavian Journal of Urology·Beata PerssonOlle Ljungqvist
Apr 30, 2015·Scandinavian Journal of Urology·Georgios GakisArnulf Stenzl
Dec 2, 2015·Experimental and Therapeutic Medicine·Weiwei FanZhilu Fan
Apr 9, 2013·European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology·C De NunzioA Tubaro
Feb 16, 2013·European Urology·Manfred P Wirth, Johannes Huber
Sep 22, 2012·European Urology·Richard E HautmannUNKNOWN International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012
Aug 25, 2012·European Urology·Georgios GakisUNKNOWN International Consultation on Urologic Disease-European Association of Urology Consultation on Bladder Cancer 2012
Mar 6, 2012·Actas urologicas españolas·A StenzlUNKNOWN European Association of Urology
Dec 20, 2011·The Journal of Urology·Nobuyuki HinataAtsushi Takenaka
Apr 21, 2012·Progrès en urologie : journal de l'Association française d'urologie et de la Société française d'urologie·Q BallouheyM Soulié
Oct 25, 2011·International Journal of Radiation Oncology, Biology, Physics·Eugene J KoayE Brian Butler
Apr 2, 2011·European Urology·Arnulf StenzlUNKNOWN European Association of Urology (EAU)
Mar 12, 2016·Arab Journal of Urology·Katie M MurrayEugene K Lee
Jan 29, 2016·BioMed Research International·Giovanni CochettiEttore Mearini
Dec 24, 2015·Advances in Urology·Wei Shen TanJohn D Kelly
Apr 9, 2016·Radiographics : a Review Publication of the Radiological Society of North America, Inc·Lauren N MoomjianAdam P Klausner
Nov 19, 2013·Urologic Oncology·Roy ManoOfer Yossepowitch
Feb 19, 2015·Current Urology Reports·Marie C HupeAxel S Merseburger
Feb 13, 2014·The Journal of Urology·Siamak DaneshmandHooman Djaladat
Jul 13, 2014·The Journal of Urology·Mihir M DesaiPeter Wiklund
Jul 5, 2016·European Urology·J Alfred WitjesMaria J Ribal

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.